Tag:

Oracle

Latest Headlines

Latest Headlines

Apple emerges as 'dominant' life sciences IT player

Apple is reaping the rewards of the popularity of its technology among life sciences companies, according to a new survey.

Oracle to snap up clinical study software-maker ClearTrial

The tech giant has struck a new buyout deal in the growing market for clinical trials software.

Medidata lauded on Wall Street; CEO takes shot at rival Oracle

Medidata Solutions ($MDSO) has impressed industry watchers with strong financial performance and sunny projections for 2012, earning the company some positive buzz in the press and at least one stock upgrade from "hold" to "buy."

NIH backs effort to integrate clinical trials data into EHRs

The National Cancer Institute (NCI), which is part of the NIH, is joining forces with Health Level Seven International (HL7) to connect trials data with electronic health records, the group announced last month.

Oracle aids Moffitt Cancer Center’s IT system for speeding patient recruitment

Slow patient recruitment looms as one of the biopharma industry's most notorious boogiemen, delaying the start of trials and prolonging the costly development process. Moffitt Cancer Center in...

Oracle announces new round of projects in IT, clinical trials

As projects generate larger quantities of more complex data, IT needs to becomes an increasingly important part of research of any kind, but particularly personalized medicine.

Emerging player in DNA analysis joins forces with U. of Missouri

Appistry, a recent entrant in the game for providing analytics for genomics data, has picked up a partnership with the University of Missouri. The university is tapping Appistry's system called

Oracle injects genomics capability into analytics platform

Oracle ($ORCL) wants to help drug researchers tap and analyze genomic data that are vital to the development of personalized therapies, which have already become key weapons in the war on cancer. The

Oracle, Parexel among leaders in CTMS market poised to hit $1.3B

Drug developers have been aiming to maximize efficiency in notoriously expensive clinical trials, and they have increased investments in clinical trial management system (CTMS) software to streamline

EDC upstart CTEP tackles Ph4 market

Dublin-based Clinical Trial EndPoint (CTEP) has found its sweet spot. With Oracle ($ORCL) glomming up big chunks of the clinical trials market for electronic data capture (EDC) software, smaller